GlassScriptPhysician profile
Carol M Dehasse
NPI 1205811205
$38,642.98
in general payments reported to CMS, 2019-2025
26 companies · $638 in 2025
The $638 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,786 · 2020: $263 · 2021: $99.18 · 2022: $8,471 · 2023: $23K · 2024: $625 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Education: $8,130 · Food and Beverage: $2,508 · Travel and Lodging: $2,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,025.00 |
| Education | $8,129.86 |
| Food and Beverage | $2,508.00 |
| Travel and Lodging | $2,360.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,867.59 | 2022-2024 | Da Vinci Surgical System |
| Acessa Health INC. | $12,054.87 | 2023 | Acessa Provu System |
| Caldera Medical, INC | $5,663.27 | 2019-2023 | Desara |
| Hologic Sales and Service, LLC | $1,277.30 | 2019-2025 | Acessa Provu System, Myosure Tissue Removal Device, Coolseal Generator |
| Momentis Surgical INC. | $1,116.45 | 2023 | Anovo Surgical System |
| Sumitomo Pharma America, INC. | $313.90 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $235.43 | 2023-2025 | Veozah |
| Biogen, INC. | $227.70 | 2025 | Zurzuvae |
| Abbvie INC. | $146.43 | 2019-2023 | Lo Loestrin Fe |
| Organon LLC | $114.83 | 2022-2025 | Nexplanon |
| Olympus America INC. | $88.20 | 2019 | |
| Becton, Dickinson and Company | $80.37 | 2023-2025 | Bd Onclarity |
| Merck Sharp & Dohme LLC | $73.34 | 2024-2025 | Gardasil 9, Gardasil |
| Mayne Pharma Commercial LLC | $53.91 | 2023 | |
| Allergan, INC. | $52.91 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $48.43 | 2024-2025 | |
| Therapeuticsmd, INC. | $37.57 | 2019 | |
| Baxter Healthcare | $36.34 | 2024-2025 | Perclot |
| Exeltis, USA INC. | $29.10 | 2023-2024 | Slynd |
| Ethicon US, LLC | $27.04 | 2025 | Stratafix |
| Sunovion Pharmaceuticals INC. | $20.50 | 2022 | |
| Gynesonics, INC. | $17.97 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Smith+Nephew, INC. | $17.59 | 2025 | "Acticoat 4"" X 4""", Pico 7, Pico 14 |
| Minerva Surgical, INC | $14.61 | 2019 | |
| Boston Scientific Corporation | $13.98 | 2020 | |
| Millicent US INC | $13.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Dehasse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.